Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non Operating Income (2019 - 2023)

Historic Non Operating Income for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$9.3 million.

  • ADC Therapeutics' Non Operating Income rose 8080.49% to -$9.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$30.4 million, marking a year-over-year decrease of 4081.88%. This contributed to the annual value of -$31034.0 for FY2022, which is 40380.81% down from last year.
  • As of Q3 2023, ADC Therapeutics' Non Operating Income stood at -$9.3 million, which was up 8080.49% from -$13.0 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Non Operating Income registered a high of $32.1 million during Q3 2020, and its lowest value of -$81.5 million during Q2 2020.
  • Moreover, its 5-year median value for Non Operating Income was $562.0 (2019), whereas its average is -$5.7 million.
  • Within the past 5 years, the most significant YoY rise in ADC Therapeutics' Non Operating Income was 181328983.05% (2020), while the steepest drop was 1287592938.39% (2020).
  • ADC Therapeutics' Non Operating Income (Quarter) stood at $562.0 in 2019, then surged by 5711109.96% to $32.1 million in 2020, then crashed by 99.98% to $6429.0 in 2021, then crashed by 247.02% to -$9452.0 in 2022, then plummeted by 97794.63% to -$9.3 million in 2023.
  • Its last three reported values are -$9.3 million in Q3 2023, -$13.0 million for Q2 2023, and -$8.1 million during Q1 2023.